The 7th Gene Therapy for Ophthalmic Disorders Summit explores cutting-edge gene therapies for ophthalmic disorders, focusing on delivery methods, preclinical and clinical strategies, and regulatory and patient engagement approaches.
Key Topics
Ocular delivery method selection and retinal targeting confirmation
Preclinical model selection and IND-enabling study design
Clinical strategy for prevalent ophthalmic therapies
Recent clinical data for rare ophthalmic regulatory submissions
Bi-functional gene therapy technologies for ocular diseases
Funding models and partnership strategies for rare therapies
Patient partnership models and retention strategies in clinical trials
Who should Attend
Researchers and scientists in ophthalmology and gene therapy
Clinical trial designers and regulatory specialists
Pharmaceutical and biotech industry professionals
Investors and partnership strategists in rare ophthalmic therapies
Medical practitioners interested in novel ocular treatments
Patient advocacy groups and engagement coordinators
